Zinzino Posts 51% Revenue Growth, Proposes 50% Dividend Increase

Zinzino AB has reported a remarkable financial performance for 2025, showcasing a strong revenue increase of 51% compared to the previous year. The company’s total revenue for the year reached SEK 3,337.5 million, up from SEK 2,207.8 million in 2024. Following this impressive growth, Zinzino’s Board of Directors is proposing a dividend hike of 50%, raising it to SEK 6.00 per share from SEK 4.00.

Quarterly Highlights and Strategic Moves

During the fourth quarter of 2025, Zinzino achieved revenue of SEK 1,035.3 million, reflecting a 45% increase over SEK 713.5 million from the same period last year. In local currencies, this surge translates to a 52% growth rate. The company’s EBITDA for the quarter soared to SEK 175.2 million, with an EBITDA margin of 16.9%, a significant rise from 10.2% in the prior year. This improvement is largely attributed to enhanced gross profit and increased synergies following the acquisition of Zurvita.

In addition to financial gains, Zinzino made strategic acquisitions, including a 35% stake in Xion International Group. This investment is aimed at establishing a sustainable supply of omega-3 through algae production, which will support Zinzino’s flagship product, BalanceOil. Furthermore, the acquisition of the direct sales company Sanki aims to bolster distribution capabilities across North and South America. The launch of the Gut Health Test also marked a significant product expansion during this quarter.

Annual Financial Performance

For the full year, Zinzino reported an EBITDA of SEK 443.4 million and an EBITDA margin of 13.3%, compared to SEK 250.7 million and 11.4% in 2024. The net profit for the year reached SEK 324.5 million, translating to a net profit per share of SEK 9.09, up from SEK 4.95 the previous year. The company also noted a cash flow from operating activities of SEK 541.8 million, a considerable increase from SEK 303.1 million in 2024.

As of December 2025, Zinzino’s cash and cash equivalents stood at SEK 771.0 million, compared to SEK 463.1 million the year prior. The Board’s proposed dividend will amount to a total of SEK 217.9 million before dilution and is set to be discussed at the Annual General Meeting scheduled for June 2, 2026.

In a further expansion effort, Zinzino announced the acquisition of It Works!, aimed at enhancing distribution power in both North America and Europe. This strategic move reflects the company’s commitment to growing its market presence and solidifying its position in the health and wellness sector.

Zinzino’s robust performance not only highlights its successful business strategies but also positions it favorably for continued growth in the coming years. For more detailed information, stakeholders can access Zinzino’s full year-end report on the company’s official website.